Market revenue in 2023 | USD 57.7 million |
Market revenue in 2030 | USD 86.6 million |
Growth rate | 6% (CAGR from 2023 to 2030) |
Largest segment | Outpatient facilities |
Fastest growing segment | Research & Manufacturing |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Hospitals, Outpatient Facilities, Research & Manufacturing |
Key market players worldwide | GE HealthCare Technologies Inc Common Stock, Abbott Laboratories, Roche Holding AG, Qiagen NV, Becton Dickinson & Co, Siemens Healthineers AG ADR, Thermo Fisher Scientific Inc, Hologic Inc, Koninklijke Philips NV, Illumina Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to blood cancer diagnostics market will help companies and investors design strategic landscapes.
Outpatient facilities was the largest segment with a revenue share of 68.28% in 2023. Horizon Databook has segmented the Saudi Arabia blood cancer diagnostics market based on hospitals, outpatient facilities, research & manufacturing covering the revenue growth of each sub-segment from 2018 to 2030.
The market for blood cancer diagnostics in South Arabia is influenced by various factors, including technological advancements, increasing awareness about blood cancer, and the rapidly aging population.
These centers, particularly in major cities like Riyadh, Jeddah, and Dammam, are equipped with advanced imaging modalities, molecular diagnostic tools, and pathology laboratories capable of conducting comprehensive diagnostic workups for hematologic malignancies.
Saudi Arabia's healthcare system is increasingly incorporating these molecular and genetic diagnostic technologies into routine clinical practices, reflecting a commitment to delivering precise & personalized care to patients with blood cancer.
Horizon Databook provides a detailed overview of country-level data and insights on the Saudi Arabia blood cancer diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into Saudi Arabia blood cancer diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account